SCHEMBL16626771

SCHEMBL16626771

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(-c3ccc(F)nc3)ccc12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.39
NR1D1 P20393 1/20 0.39
IDE P14735 1/20 0.37
EPHX2 P34913 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
PDPK1 O15530 1/20 0.35
RORC P51449 2/20 0.35
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
MAP2K7 O14733 1/20 0.35
MAP2K4 P45985 1/20 0.35
PDE2A O00408 2/20 0.35
PDE5A O76074 2/20 0.35
PDE11A Q9HCR9 2/20 0.35
PDE10A Q9Y233 2/20 0.35
SSTR5 P35346 1/20 0.34
KCNH2 Q12809 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618564 0.99 NR1D1 (0.38) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL16626637 0.92 NR1D1 (0.38) HTR6NR1D1IDEEPHX2PRMT6
Hydrochloric Acid SCHEMBL16619510 0.91 NR1D1 (0.38) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL17971569 0.89 GRIN2B (0.39) HTR6NR1D1IDEPDPK1
Hydrochloric Acid SCHEMBL16618679 0.88 GRIN2B (0.39) HTR6NR1D1IDEPDPK1RORC
SCHEMBL16619172 0.88 HTR6 (0.46) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL16619000 0.88 HTR6 (0.46) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL16619135 0.88 HTR6 (0.38) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL17971570 0.87 HTR6 (0.40) HTR6NR1D1IDEEPHX2PRMT6
SCHEMBL17971571 0.87 HTR6 (0.39) HTR6NR1D1IDEPDPK1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885NR1D1 2493/4885IDE 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.